We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Microbe Biomarkers Reveal Evidence of Radiation Exposure

By LabMedica International staff writers
Posted on 14 Jun 2012
Researchers have identified unique biomarkers that could be used to confirm exposure to damaging radiation in large groups of individuals potentially exposed to unknown and variable doses for the purpose of triage and treatment.

The findings are published in the May 1, 2012, issue of the journal Radiation Research. More...
John E. Baker, PhD, professor of surgery, biochemistry, pharmacology, and toxicology at the Medical College of Wisconsin (Milwaukee, USA), is the lead author of the study.

There is an urgent need for fast, precise, and sensitive diagnostic platforms to validate exposure to radiation and estimate the dose absorbed by individuals. Clinical symptoms do not provide sufficient diagnostic information to triage and treat life-threatening radiation injuries; furthermore, the United States has been found to be unprepared to assess and triage large groups of patients with potential radiation exposure.

In this study, researchers examined the microbes found in rat feces before and after exposure to radiation. Alterations were identified in the levels of 212 genomically unique bacteria, of which 59 are found in humans. Those changes persisted at least 21 days following the exposure to radiation. One particular type of microbe, Proteobacteria, increased nearly 1,000- fold four days following irradiation.

“If there were to be a radiological terrorism scenario, there could be hundreds of thousands of people that would be present around the ground zero area, and limited medical resources available to evaluate their exposure levels,” explained Dr. Baker. “Analyzing microbial signatures in those patients would be a noninvasive way to obtain results in a timely fashion, and allow us to commit resources to patients in need of intervention.”

The PhyloChip assay, developed by Second Genome (San Bruno, CA, USA), was used in this study to examine specific bacterial taxa.

Related Links:

Medical College of Wisconsin



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.